UA39859C2 - Похідні 5-аміно-8-метил-7-піролідинілхінолін-3-карбонової кислоти, спосіб їх одержання (варіанти), фармацевтична композиція, спосіб лікування інфекційних захворювань, проміжна сполука - Google Patents

Похідні 5-аміно-8-метил-7-піролідинілхінолін-3-карбонової кислоти, спосіб їх одержання (варіанти), фармацевтична композиція, спосіб лікування інфекційних захворювань, проміжна сполука

Info

Publication number
UA39859C2
UA39859C2 UA94005280A UA94005280A UA39859C2 UA 39859 C2 UA39859 C2 UA 39859C2 UA 94005280 A UA94005280 A UA 94005280A UA 94005280 A UA94005280 A UA 94005280A UA 39859 C2 UA39859 C2 UA 39859C2
Authority
UA
Ukraine
Prior art keywords
epoxy
resin
heat
polymers
binder
Prior art date
Application number
UA94005280A
Other languages
English (en)
Ukrainian (uk)
Inventor
Яшіо Іто
Хідео Като
Сінго Ясуда
Норіюкі Кадо
Тошіхіко Йошіда
Йоічі Ямамото
Original Assignee
Хокуріку Сеяку Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хокуріку Сеяку Ко., Лтд filed Critical Хокуріку Сеяку Ко., Лтд
Publication of UA39859C2 publication Critical patent/UA39859C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Epoxy Resins (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
UA94005280A 1993-08-27 1994-06-27 Похідні 5-аміно-8-метил-7-піролідинілхінолін-3-карбонової кислоти, спосіб їх одержання (варіанти), фармацевтична композиція, спосіб лікування інфекційних захворювань, проміжна сполука UA39859C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23431093 1993-08-27
JP28627293 1993-10-22
JP7631894 1994-03-24

Publications (1)

Publication Number Publication Date
UA39859C2 true UA39859C2 (uk) 2001-07-16

Family

ID=27302121

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94005280A UA39859C2 (uk) 1993-08-27 1994-06-27 Похідні 5-аміно-8-метил-7-піролідинілхінолін-3-карбонової кислоти, спосіб їх одержання (варіанти), фармацевтична композиція, спосіб лікування інфекційних захворювань, проміжна сполука

Country Status (23)

Country Link
US (1) US5547962A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0641793B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2673937B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100218807B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1048242C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE144508T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU676729B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2126118C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ286524B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69400791T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0641793T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2096413T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI113174B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3021715T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU221952B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL110060A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY111702A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO305515B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ260851A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL175870B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG52147A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW252107B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA39859C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1183778A (zh) * 1995-01-24 1998-06-03 北陆制药株式会社 喹啉羧酸衍生物
US6121285A (en) 1995-11-22 2000-09-19 Daiichi Pharmaceutical Co., Ltd. Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
NZ503740A (en) 1997-09-15 2002-09-27 Procter & Gamble Antimicrobial quinolones, their compositions and uses
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
US6531624B1 (en) 1998-11-18 2003-03-11 Asahi Glass Company Ltd. Aminoacrylic acid derivatives and process for producing the same
CA2367373C (en) 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
DE60135640D1 (de) * 2000-02-09 2008-10-16 Daiichi Sankyo Co Ltd Rielle mittel die pyridincarbonsäuren als aktiven wirkstoff enthalten
US6825353B2 (en) 2000-02-25 2004-11-30 Daiichi Pharmaceutical Co., Ltd. Process for producing quinolonecarboxylic acids and intermediates thereof
CN1426399A (zh) * 2000-02-25 2003-06-25 第一制药株式会社 喹诺酮甲酸及其中间体的制备方法
KR20010044286A (ko) * 2001-02-01 2001-06-05 남근수 알킬-3-(2,6-디할로겐-5-플루오로)-옥소-3-피리딘프로피오네이트의 제조방법
US7928232B2 (en) * 2005-05-20 2011-04-19 Daiichi Sankyo Company, Limited Method for producing asymmetric tetrasubstituted carbon atom-containing compound
JP5073497B2 (ja) * 2005-09-28 2012-11-14 第一三共株式会社 テトラ置換−5−アザスピロ[2.4]へプタン誘導体の製法およびその光学活性中間体
ATE507219T1 (de) * 2006-03-28 2011-05-15 Warner Chilcott Co Llc Malatsalze und polymorphe von (3s,5s)-7-ä3-amino- 5-methyl-piperidinylü-1-cyclopropyl-1,4-dihydro 8-methoxy-4-oxo-3-chinolincarbonsäure
US7528264B2 (en) * 2006-03-28 2009-05-05 The Procter & Gamble Company Hydride reduction process for preparing quinolone intermediates
BRPI0709220A2 (pt) * 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
TWI362386B (en) 2007-03-30 2012-04-21 Daiichi Sankyo Co Ltd A production method for the qunolon-carboxylic acid derivative
FR2928150A1 (fr) * 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
JPH0637489B2 (ja) * 1985-09-21 1994-05-18 杏林製薬株式会社 キノロンカルボン酸誘導体およびその製造方法
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
IL83049A (en) * 1986-07-04 1991-12-12 Chemie Linz Ag 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
JPS63152318A (ja) * 1986-08-07 1988-06-24 Dainippon Pharmaceut Co Ltd 抗マイコプラズマ剤
US5190955A (en) * 1987-01-28 1993-03-02 Bayer Aktiengesellschaft Antibacterial 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JPS63275567A (ja) * 1987-05-07 1988-11-14 Dainippon Pharmaceut Co Ltd 新規キノリン誘導体、そのエステルおよびその塩
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
JPH0219377A (ja) * 1988-07-08 1990-01-23 Kyorin Pharmaceut Co Ltd 8‐メチルキノロンカルボン酸誘導体
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
IE76284B1 (en) * 1988-09-22 1997-10-08 Abbott Lab Amino acid quinoline and naphthyridine derivatives
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
CA2012063A1 (en) * 1989-03-15 1990-09-15 Hirosato Kondo Quinolinecarboxylic acid derivatives and antibacterial agent containing the same
DE69019859T2 (de) * 1989-03-30 1995-10-05 Wakunaga Seiyaku Kk Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
DE3910920A1 (de) * 1989-04-05 1990-10-11 Bayer Ag Enantiomerenreine 7-(3-amino-1-pyrrolidinyl)-chinolon- und -naphthyridoncarbonsaeuren
DE4032560A1 (de) * 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
DE69132314T2 (de) * 1990-12-05 2000-12-14 Naeja Pharmaceutical Inc., Edmonton 7-substituierte-6-fluor-1,4-dihydro-4-oxo-chinolin-3-carbonsäurederivate als antibakterielle wirkstoffe
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체

Also Published As

Publication number Publication date
JPH07309864A (ja) 1995-11-28
FI113174B (fi) 2004-03-15
CA2126118A1 (en) 1995-02-28
HU221952B1 (hu) 2003-03-28
EP0641793A1 (en) 1995-03-08
FI942976A0 (fi) 1994-06-21
AU6487094A (en) 1995-03-09
CZ157494A3 (en) 1995-10-18
US5547962A (en) 1996-08-20
HUT67259A (en) 1995-03-28
JP2673937B2 (ja) 1997-11-05
NO942309L (no) 1995-02-28
AU676729B2 (en) 1997-03-20
PL304063A1 (en) 1995-03-06
CA2126118C (en) 2001-02-06
IL110060A (en) 1999-10-28
HU9401954D0 (en) 1994-09-28
MY111702A (en) 2000-11-30
ES2096413T3 (es) 1997-03-01
NO942309D0 (no) 1994-06-17
NO305515B1 (no) 1999-06-14
TW252107B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-07-21
PL175870B1 (pl) 1999-02-26
ATE144508T1 (de) 1996-11-15
KR100218807B1 (ko) 1999-09-01
SG52147A1 (en) 1998-09-28
IL110060A0 (en) 1994-10-07
GR3021715T3 (en) 1997-02-28
FI942976A7 (fi) 1995-02-28
DE69400791D1 (de) 1996-11-28
CN1048242C (zh) 2000-01-12
NZ260851A (en) 1996-03-26
EP0641793B1 (en) 1996-10-23
DK0641793T3 (da) 1996-11-25
KR950005823A (ko) 1995-03-20
CZ286524B6 (cs) 2000-05-17
CN1117491A (zh) 1996-02-28
DE69400791T2 (de) 1997-03-06

Similar Documents

Publication Publication Date Title
UA39944C2 (uk) Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
UA43347C2 (uk) Спосіб лікування психічних захворювань
UA39859C2 (uk) Похідні 5-аміно-8-метил-7-піролідинілхінолін-3-карбонової кислоти, спосіб їх одержання (варіанти), фармацевтична композиція, спосіб лікування інфекційних захворювань, проміжна сполука
UA39940C2 (uk) Посудина безбар'єрного типу та спосіб її експлуатації
US4366108A (en) Liquid matrix system based on a mixture of epoxide resin and an amine curing agent for producing fibre-reinforced plastics components
CN109929109A (zh) 一种高韧性耐高低温双马来酰亚胺树脂预聚物及其制备方法
Yusoff et al. Curing of polymeric composites using microwave resin transfer moulding (RTM)
UA39851C2 (uk) Спосіб одержання складних ефірів 2,2-диметил-3-[(z)-1-пропеніл]циклопропанкарбонової кислоти та проміжні сполуки
Lorwanishpaisarn et al. Carbon fiber/epoxy vitrimer composite patch cured with bio‐based curing agents for one‐step repair metallic sheet and its recyclability
Liang et al. Influence of topological structure on mechanical property of recyclable bio-based hyperbranched epoxy/carbon fiber fabric composites
Chekanov et al. Cure shrinkage defects in epoxy resins
Liu et al. Solid freeform fabrication of epoxidized soybean oil/epoxy composites with di‐, tri‐, and polyethylene amine curing agents
US5672311A (en) Process for preparing thermoset composite articles
US4126598A (en) Concrete electrical insulator
Liu et al. Bio-based epoxies and composites as environmentally friendly alternative materials
Robertson Resin transfer moulding of aerospace resins—a review
JPS5927916A (ja) エポキシ樹脂組成物およびエポキシ樹脂の加工性改善方法
KR910020104A (ko) 난연성 및 내고온성 중합형 수지 제조용 경화 수지, 이 중합형 수지의 제조 방법 및 용도
UA43336C2 (uk) ПОХІДНІ О<sup>6</sup>-АЛКІЛГУАНІНУ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ
UA39980C2 (uk) Спосіб приготування електроліту для електролітичних конденсаторів
US5971071A (en) Method of using thermosetting compositions with improved latency
CN106117980A (zh) 一种原位自增强树脂体系及其制备方法
US3556831A (en) Method for sealing leaks in pressurized vessels
BR8403610A (pt) Processo para a producao de materiais de moldagem de resina epoxido e aplicacao
CN103265793A (zh) 可内部修复的碳纤维增强环氧树脂基复合材料及制备方法